Introduction

Cohort plc (LSE:CHRT) is a defence and security technology group that has become one of AIM’s standout performers, riding a wave of rising global defence spending. Comprising a portfolio of specialist businesses serving navies, armed forces and security agencies, Cohort (CHRT) offers investors exposure to a structurally growing market with long-dated, high-visibility contracts. A record order book and rising Dividend have underscored the strength of its position.

Why Cohort (CHRT) is in focus now

Cohort (CHRT) is in focus because its order book has reached record levels amid a surge in defence spending across NATO and allied nations. The group has reported Revenue growth and a strong intake of new orders, giving it visibility extending well into the 2030s. With governments increasing military budgets in response to a more uncertain geopolitical environment, Cohort’s specialist defence businesses are well placed, and the company has continued to raise its dividend, reinforcing its appeal.

Business overview

Cohort operates a decentralised model, owning a portfolio of specialist defence and security technology businesses. These provide products and services including naval communications and sonar, electronic warfare, surveillance, Training and advisory services, and digital solutions, serving customers in the UK and internationally. The group’s strategy combines organic growth within its operating companies with selective acquisitions that add capability and scale. Its work is largely tied to defence procurement, which provides long-term, often multi-year, contracted revenue and high visibility.

Latest Earnings explained

For the first half of its 2025/26 financial year (the six months to 31 October 2025), Cohort reported revenue up about 9% to roughly £128.8m, with adjusted operating profit slightly lower at about £9.7m, against £10.1m a year earlier, reflecting some Margin pressure and the typical second-half weighting of its business. The order book stood at a near-record £604.5m, with order intake of about £122.3m covering around 96% of full-year revenue forecasts. In a year-end update, Cohort indicated full-year revenue rising about 12% to around £303m with adjusted operating profit of roughly £36m, ahead of expectations, with audited results to follow.

Revenue, profit, margins, Cash Flow and Balance Sheet

Cohort’s first-half profitability dipped slightly even as revenue grew, reflecting mix and the phasing of its work towards the second half, but full-year guidance pointed to a net margin around 12% and a stronger second half. The order book covering around 96% of full-year revenue at the half-year stage, and providing coverage of roughly 80% of the following year’s expected revenue, gives Cohort strong earnings visibility. The group has historically maintained a sound balance sheet, supporting both acquisitions and a progressive dividend, with cash generation underpinning Shareholder returns.

What management said

Management highlighted the record order book and strong order intake as evidence of robust Demand, and reaffirmed full-year guidance, pointing to a stronger second-half performance in line with the group’s normal pattern. Commentary emphasised the supportive backdrop of rising defence budgets and the long-term visibility provided by Cohort’s contracted work. The decision to raise the dividend reflected confidence in cash generation, while management reiterated a disciplined approach to acquisitions as a source of future growth.

Latest news and announcements

Recent developments include the half-year results showing revenue growth and the record order book, the 10% increase in the Interim Dividend to 5.80p per share, and the year-end indication of full-year revenue of around £303m and adjusted operating profit of about £36m, ahead of expectations. Cohort regularly announces contract wins across its operating businesses and pursues acquisitions, both of which are central to its growth and to maintaining its strong order book.

Share-price performance and market reaction

Cohort (CHRT) shares have traded around 1,274p and have performed strongly, supported by the structural rise in defence spending and the group’s record order book. The shares have rerated as investors have sought defence exposure, which can leave them sensitive to expectations and to news on contracts and margins. As with all defence stocks, sentiment can also be affected by political and budgetary developments, although the long-term spending backdrop has been supportive.

Growth drivers

The main growth drivers for Cohort (CHRT) are rising global defence budgets, particularly across NATO members, which are increasing procurement of the kinds of technology Cohort supplies; the group’s record order book, which underpins revenue visibility; organic growth within its specialist businesses; and selective acquisitions that add capability and scale. Export opportunities and the long-term nature of defence programmes provide durable demand, while operational improvements can support margins.

Key risks for investors

Cohort faces risks including dependence on government defence budgets and procurement decisions, which can be subject to political change and timing delays. Margin pressure, as seen in the first half, can arise from contract mix and cost Inflation. The group’s decentralised, acquisitive model carries integration and execution risk. Programme delays or cancellations could affect revenue, and the shares’ rerating means they could be vulnerable if growth or margins disappoint. Some contracts carry execution and delivery risk inherent in complex defence technology.

Dividend position

Cohort (CHRT) is a progressive dividend payer, having raised its interim dividend by about 10% to 5.80p per share, supported by strong cash generation and a solid balance sheet. While the Yield is modest, the combination of dividend growth and high earnings visibility from the order book makes the income component a meaningful, if secondary, part of the Investment case alongside the group’s growth prospects.

Outlook for the next 6–12 months

Over the next 6–12 months, Cohort’s prospects are underpinned by its record order book and the supportive defence-spending environment. Investors will look to the audited full-year results to confirm the ahead-of-expectations performance indicated at the year-end, and will watch for further contract wins, margin progression and any acquisitions. The main risks to monitor are defence-budget and procurement timing, and cost pressures. The high order cover provides a strong foundation for the period ahead.

Investor takeaway

Cohort (CHRT) offers exposure to rising global defence spending through a portfolio of specialist technology businesses, backed by a record order book that provides exceptional revenue visibility. The investment case rests on sustained defence budgets, order conversion and disciplined acquisitions, balanced against budgetary, margin and execution risks and a rerated share price. This article is for information only and is not financial advice; investors should do their own research.

 

Top of Form

Bottom of Form